维普期刊资源整合服务平台（V6.5）

29篇 您的检索式：作者名="Yoeruek"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Human anterior lens capsule as carrier matrix forcultivated human comeal endothelial cells显示文摘	Yoeruek E Saygili O Spitzer MS Tatar O Bartz-Schmidt KU Szurman P	2009	Cornea2009，28，41：	1
2	Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells显示文摘	Yoeruek E Saygili O Spitzer MS		0，，：	1
3	Safety,penetration and efficacy of topically applied bevacizumab:evaluation of eyedrops in corneal neovascularization after chemical burn显示文摘	Yoeruek E Ziemssen F Henke-Fahle S	2008	Acta Ophthalmol2008，86，：	1
4	Comparative antiproliferative and eytotoxic profile of bevacizumab (Avastin) , pegaptanib (Macugen) and ranibizumab (Lucentis) on different ocular cells 显示文摘	Spitzer MS Yoeruek E Sierra A	2007	Graefe'' s Arch Clin Exp Ophthalmol2007，245，：	1
5	Safety penetration and efficacy of topically applied bevacizumab:evaluation of eyedrops in corneal neovascularization after chemical bum显示文摘	Yoeruek E Ziem ssen F Henke-Fahle S		0，，3：	1
6	Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells 显示文摘	Yoeruek E Saygili O Spitzer MS	2009	Cornea2009，28，4：	1
7	Safety, penetration and efficacy of topically applied bevacizumab: Evaluation of eyedrops in corneal neovascularization after chemical burn 显示文摘	Yoeruek E Ziemssen F Henke-Fahle S Tatar O Tufa A Grisanti S	2008	Acta Ophthalmologica Scandinavica2008，85，3：	1
8	Safety profile of a taufine containing irrigation solution (AcriProTeet) in pars plana vitreetomy 显示文摘	Yoeruek E Jagle H Luke M	2007	Retina2007，27，9：	1
9	Safety profile of bevaeizumab on cultured human comeal cells显示文摘	Yoeruek E Splitzer MS Tatar O	2007	Cornea2007，26，8：	1
10	Human anterior lens capsule as carrier matrix for cultivated human comeal endothelial cells显示文摘	Yoeruek E Saygili O Spitzer MS	2009	Comea2009，28，4：	1
11	Safety profile of bevacizumab on cultured human corneal cells显示文摘	Yoeruek E Spitzer MS Tatar O Aisenbrey S Bartz-Schmidt KU Szurman P	2007	Cornea2007，25，8：	1
12	Safety profile of bevacizumab on cultured human corneal cells显示文摘	Yoeruek E Spitzer MS Tatar O Aisenbrey S Bartz-Schmidt KU Szurman P		Cornea0，25，8：	1
13	Safety profile of bevacizumab on cultured human corneal cells显示文摘	Yoeruek E Spitzer MS Tatar O		0，，08：	1
14	Safety profile of bevacizumab on cultured human corneal cells显示文摘	Yoeruek E Spitzer MS Tatar O		0，，08：	1
15	Safety penetration and efficacy of topically applied bevacizumab : evaluation of eyedrops in corneal neovascularization after chemical burn 显示文摘	Yoeruek E Ziemssen F Henke-Fahle S Tatar O Tura A Grisanti S	2008	Acta Ophthalmol2008，86，3：	1
16	Safety profile of bevacizumab on cultured human corneal cells 显示文摘	Yoeruek E Spitzer MS Tatar O Aisenbrey S Bartz-Schraidt KU Szurman P	2007	Cornea2007，26，8：	1
17	Effect of bevacizumab oninflammation and proliferation in human choroidal neovascularization显示文摘	Tatar 0 Yoeruek E Szurman P	2008	Arch Ophthalmol2008，126，6：	1
18	Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells 显示文摘	Yoeruek E Saygili O Spitzer MS Tatar O Bartz-Schmidt KU Szurman P	2009	Cornea2009，28，4：	1
19	Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema显示文摘	Spitzer MS Ziemssen F Yoeruek E	2008	J Cataract Refract Surg2008，34，1：	1
20	Effect of bevacizumab inflammation and proliferation in human choroidal neovascularization显示文摘	Tatar O Yoeruek E Szurman P	2008	Arch OphthaImol2008，126，6：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示